论文标题
纯合GRN突变:意外的表型以及对病理和分子机制的新见解
Homozygous GRN mutations: unexpected phenotypes and new insights into pathological and molecular mechanisms
论文作者
论文摘要
前素蛋白基因(GRN)中的纯合突变与神经元蛋白脂肪促肌动症11(CLN11)是一种罕见的溶酶体储存障碍,其特征是小脑共济失调,癫痫发作,视网膜炎,色素性疾病和认知障碍,通常在13岁和25岁之间开始。这是一种罕见的状况,以前仅在四个家庭中报道过。相反,杂合子GRN突变是与神经元细胞质TDP-43夹杂物相关的额颞痴呆的主要原因。我们确定了六名新患者的纯合GRN突变。表型频谱比以前报道的要广泛得多,两种截然不同的演示,具体取决于发作的年龄。童年/少年形式的特征是在发病时期从小就出现经典的CLN11症状。出乎意料的是,其他纯合患者在50年后提出了额颞痴呆和帕金森氏症的明显延迟表型。没有人患有癫痫病或小脑共济失调。这项研究的另一个主要发现是,所有GRN突变可能不会对progranulin蛋白的合成产生相同的影响。在一种情况下,存在纯合剪接位点突变和晚期发作额颞痴呆,在一种情况下存在残留水平的血浆前血浆蛋白和低水平的正常转录本,支持某些突变的低外形作用。这是一个新的关键发现,在基于替代策略的治疗试验中必须考虑。纯合载体中的首次神经病理学研究为疾病的病理机制提供了新的见解。存在神经元的脂肪促脂肪铁的标志。 TDP-43细胞质夹杂物的缺失明显不同于观察到杂合突变的观察结果,这表明溶酶体和TDP-43病理学之间的病理转移,这取决于单声道或双行状态。一个有趣的观察结果是一些神经元细胞核中正常TDP-43染色的丧失,这可能是在典型细胞质内包含的形成之前的TDP-43病理过程的第一阶段。最后,这项研究对遗传咨询和分子诊断具有重要意义。 GRN突变的半主导遗传意味着应将特定的遗传咨询交付给CLN11患者的儿童和父母,因为它们是杂合携带者,具有痴呆症的高风险。更广泛地说,这项研究说明了一个事实,即遗传变异可以根据单相或双行状态导致不同的表型,这是遗传诊断的挑战。
Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar ataxia, seizures, retinitis pigmentosa, and cognitive disorders, usually beginning between 13 and 25 years of age. This is a rare condition, previously reported in only four families. In contrast, heterozygous GRN mutations are a major cause of frontotemporal dementia associated with neuronal cytoplasmic TDP-43 inclusions. We identified homozygous GRN mutations in six new patients. The phenotypic spectrum is much broader than previously reported, with two remarkably distinct presentations, depending on the age of onset. A childhood/juvenile form is characterized by classical CLN11 symptoms at an early age at onset. Unexpectedly, other homozygous patients presented a distinct delayed phenotype of frontotemporal dementia and parkinsonism after 50 years; none had epilepsy or cerebellar ataxia. Another major finding of this study is that all GRN mutations may not have the same impact on progranulin protein synthesis. A hypomorphic effect of some mutations is supported by the presence of residual levels of plasma progranulin and low levels of normal transcript detected in one case with a homozygous splice-site mutation and late onset frontotemporal dementia. This is a new critical finding that must be considered in therapeutic trials based on replacement strategies. The first neuropathological study in a homozygous carrier provides new insights into the pathological mechanisms of the disease. Hallmarks of neuronal ceroid lipofuscinosis were present. The absence of TDP-43 cytoplasmic inclusions markedly differs from observations of heterozygous mutations, suggesting a pathological shift between lysosomal and TDP-43 pathologies depending on the mono or bi-allelic status. An intriguing observation was the loss of normal TDP-43 staining in the nucleus of some neurons, which could be the first stage of the TDP-43 pathological process preceding the formation of typical cytoplasmic inclusions. Finally, this study has important implications for genetic counselling and molecular diagnosis. Semi-dominant inheritance of GRN mutations implies that specific genetic counseling should be delivered to children and parents of CLN11 patients, as they are heterozygous carriers with a high risk of developing dementia. More broadly, this study illustrates the fact that genetic variants can lead to different phenotypes according to their mono- or bi-allelic state, which is a challenge for genetic diagnosis.